Do analysts recommend CRW or EMIS?

Craneware currently has a consensus target price of GBX 2,297.75, indicating a potential upside of 58.25%. Given Craneware's stronger consensus rating and higher probable upside, equities research analysts clearly believe Craneware is more favorable than EMIS Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Craneware 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 EMIS Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better earnings and valuation, CRW or EMIS?

EMIS Group has lower revenue, but higher earnings than Craneware. EMIS Group is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Craneware £211.33M 2.35 £14.27M £62.90 23.08 EMIS Group £176.86M 0.00 £30.48M £0.47 N/A

Is CRW or EMIS more profitable?

EMIS Group has a net margin of 17.23% compared to Craneware's net margin of 10.63%. EMIS Group's return on equity of 23.17% beat Craneware's return on equity. Company Net Margins Return on Equity Return on Assets Craneware 10.63% 6.65% 2.28% EMIS Group 17.23% 23.17% 7.99%

Do analysts rate CRW or INS?

Craneware currently has a consensus target price of GBX 2,297.75, indicating a potential upside of 58.25%. Given Craneware's stronger consensus rating and higher possible upside, research analysts plainly believe Craneware is more favorable than Instem. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Craneware 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Instem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings & valuation, CRW or INS?

Craneware has higher revenue and earnings than Instem. Instem is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Craneware £211.33M 2.35 £14.27M £62.90 23.08 Instem £61.63M 0.00 £3.34M £0.14 N/A

Is CRW or INS more profitable?

Craneware has a net margin of 10.63% compared to Instem's net margin of 5.50%. Craneware's return on equity of 6.65% beat Instem's return on equity. Company Net Margins Return on Equity Return on Assets Craneware 10.63% 6.65% 2.28% Instem 5.50% 6.35% 4.62%

Which has higher valuation & earnings, KOO or CRW?

Craneware has higher revenue and earnings than Kooth. Kooth is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Kooth £63.29M 0.92 £4.00M £7.00 23.00 Craneware £211.33M 2.35 £14.27M £62.90 23.08

Is KOO or CRW more profitable?

Craneware has a net margin of 10.63% compared to Kooth's net margin of 4.12%. Kooth's return on equity of 8.84% beat Craneware's return on equity. Company Net Margins Return on Equity Return on Assets Kooth 4.12% 8.84% 10.12% Craneware 10.63% 6.65% 2.28%

Do analysts rate INHC or CRW?

Craneware has a consensus price target of GBX 2,297.75, indicating a potential upside of 58.25%. Given Craneware's stronger consensus rating and higher probable upside, analysts plainly believe Craneware is more favorable than Induction Healthcare Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Induction Healthcare Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Craneware 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00

Craneware (CRW) Competitors

GBX 1,452 +12.00 (+0.83%)

As of 12:16 PM Eastern

Compare

CRW vs. EMIS, INS, KOO, COG, and INHC

Should you buy Craneware stock or one of its competitors? MarketBeat compares Craneware with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Craneware include EMIS Group (EMIS), Instem (INS), Kooth (KOO), Cambridge Cognition (COG), and Induction Healthcare Group (INHC). These companies are all part of the "health information services" industry.

How does Craneware compare to EMIS Group?

Craneware (LON:CRW) and EMIS Group (LON:EMIS) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, dividends, institutional ownership, profitability and valuation.

In the previous week, Craneware had 1 more articles in the media than EMIS Group. MarketBeat recorded 1 mentions for Craneware and 0 mentions for EMIS Group. Craneware's average media sentiment score of 0.00 equaled EMIS Group'saverage media sentiment score.

Company	Overall Sentiment
Craneware	Neutral
EMIS Group	Neutral

Craneware currently has a consensus target price of GBX 2,297.75, indicating a potential upside of 58.25%. Given Craneware's stronger consensus rating and higher probable upside, equities research analysts clearly believe Craneware is more favorable than EMIS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Craneware	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
EMIS Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Craneware has a beta of 0.28, indicating that its share price is 72% less volatile than the broader market. Comparatively, EMIS Group has a beta of -0.13, indicating that its share price is 113% less volatile than the broader market.

EMIS Group has lower revenue, but higher earnings than Craneware. EMIS Group is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Craneware	£211.33M	2.35	£14.27M	£62.90	23.08
EMIS Group	£176.86M	0.00	£30.48M	£0.47	N/A

36.4% of Craneware shares are owned by institutional investors. Comparatively, 105.6% of EMIS Group shares are owned by institutional investors. 10.3% of Craneware shares are owned by insiders. Comparatively, 3.6% of EMIS Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Craneware pays an annual dividend of GBX 41.96 per share and has a dividend yield of 2.9%. EMIS Group pays an annual dividend of GBX 42 per share. Craneware pays out 66.7% of its earnings in the form of a dividend. EMIS Group pays out 8,936.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Craneware is clearly the better dividend stock, given its higher yield and lower payout ratio.

EMIS Group has a net margin of 17.23% compared to Craneware's net margin of 10.63%. EMIS Group's return on equity of 23.17% beat Craneware's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Craneware	10.63%	6.65%	2.28%
EMIS Group	17.23%	23.17%	7.99%

Summary

Craneware beats EMIS Group on 10 of the 16 factors compared between the two stocks.

How does Craneware compare to Instem?

Craneware (LON:CRW) and Instem (LON:INS) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

Craneware has higher revenue and earnings than Instem. Instem is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Craneware	£211.33M	2.35	£14.27M	£62.90	23.08
Instem	£61.63M	0.00	£3.34M	£0.14	N/A

36.4% of Craneware shares are held by institutional investors. Comparatively, 65.9% of Instem shares are held by institutional investors. 10.3% of Craneware shares are held by insiders. Comparatively, 30.0% of Instem shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Craneware has a net margin of 10.63% compared to Instem's net margin of 5.50%. Craneware's return on equity of 6.65% beat Instem's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Craneware	10.63%	6.65%	2.28%
Instem	5.50%	6.35%	4.62%

Craneware currently has a consensus target price of GBX 2,297.75, indicating a potential upside of 58.25%. Given Craneware's stronger consensus rating and higher possible upside, research analysts plainly believe Craneware is more favorable than Instem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Craneware	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
Instem	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Craneware has a beta of 0.28, meaning that its stock price is 72% less volatile than the broader market. Comparatively, Instem has a beta of 0.42, meaning that its stock price is 58% less volatile than the broader market.

In the previous week, Craneware had 1 more articles in the media than Instem. MarketBeat recorded 1 mentions for Craneware and 0 mentions for Instem. Craneware's average media sentiment score of 0.00 equaled Instem'saverage media sentiment score.

Company	Overall Sentiment
Craneware	Neutral
Instem	Neutral

Summary

Craneware beats Instem on 9 of the 14 factors compared between the two stocks.

How does Craneware compare to Kooth?

Kooth (LON:KOO) and Craneware (LON:CRW) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends.

Kooth has a beta of 1.238, indicating that its share price is 24% more volatile than the broader market. Comparatively, Craneware has a beta of 0.28, indicating that its share price is 72% less volatile than the broader market.

21.0% of Kooth shares are held by institutional investors. Comparatively, 36.4% of Craneware shares are held by institutional investors. 30.4% of Kooth shares are held by company insiders. Comparatively, 10.3% of Craneware shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Kooth presently has a consensus target price of GBX 330, suggesting a potential upside of 104.97%. Craneware has a consensus target price of GBX 2,297.75, suggesting a potential upside of 58.25%. Given Kooth's higher probable upside, research analysts clearly believe Kooth is more favorable than Craneware.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kooth	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Craneware	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Craneware has a net margin of 10.63% compared to Kooth's net margin of 4.12%. Kooth's return on equity of 8.84% beat Craneware's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kooth	4.12%	8.84%	10.12%
Craneware	10.63%	6.65%	2.28%

Craneware has higher revenue and earnings than Kooth. Kooth is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kooth	£63.29M	0.92	£4.00M	£7.00	23.00
Craneware	£211.33M	2.35	£14.27M	£62.90	23.08

In the previous week, Craneware had 1 more articles in the media than Kooth. MarketBeat recorded 1 mentions for Craneware and 0 mentions for Kooth. Kooth's average media sentiment score of 0.00 equaled Craneware'saverage media sentiment score.

Company	Overall Sentiment
Kooth	Neutral
Craneware	Neutral

Summary

Craneware beats Kooth on 9 of the 14 factors compared between the two stocks.

How does Craneware compare to Cambridge Cognition?

Cambridge Cognition (LON:COG) and Craneware (LON:CRW) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, media sentiment, institutional ownership and profitability.

15.9% of Cambridge Cognition shares are held by institutional investors. Comparatively, 36.4% of Craneware shares are held by institutional investors. 3.3% of Cambridge Cognition shares are held by company insiders. Comparatively, 10.3% of Craneware shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Cambridge Cognition currently has a consensus price target of GBX 56, indicating a potential upside of 53.42%. Craneware has a consensus price target of GBX 2,297.75, indicating a potential upside of 58.25%. Given Craneware's higher possible upside, analysts plainly believe Craneware is more favorable than Cambridge Cognition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cambridge Cognition	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Craneware	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Craneware has a net margin of 10.63% compared to Cambridge Cognition's net margin of -17.82%. Craneware's return on equity of 6.65% beat Cambridge Cognition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cambridge Cognition	-17.82%	-62.89%	-0.30%
Craneware	10.63%	6.65%	2.28%

Cambridge Cognition has a beta of 0.737, indicating that its stock price is 26% less volatile than the broader market. Comparatively, Craneware has a beta of 0.28, indicating that its stock price is 72% less volatile than the broader market.

In the previous week, Craneware had 1 more articles in the media than Cambridge Cognition. MarketBeat recorded 1 mentions for Craneware and 0 mentions for Cambridge Cognition. Cambridge Cognition's average media sentiment score of 0.00 equaled Craneware'saverage media sentiment score.

Company	Overall Sentiment
Cambridge Cognition	Neutral
Craneware	Neutral

Craneware has higher revenue and earnings than Cambridge Cognition. Cambridge Cognition is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cambridge Cognition	£9.40M	1.81	-£1.58M	-£3.90	N/A
Craneware	£211.33M	2.35	£14.27M	£62.90	23.08

Summary

Craneware beats Cambridge Cognition on 13 of the 14 factors compared between the two stocks.

How does Craneware compare to Induction Healthcare Group?

Induction Healthcare Group (LON:INHC) and Craneware (LON:CRW) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations.

Craneware has higher revenue and earnings than Induction Healthcare Group. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Induction Healthcare Group	£12.57M	0.72	-£5.12M	-£5.54	N/A
Craneware	£211.33M	2.35	£14.27M	£62.90	23.08

Craneware has a consensus price target of GBX 2,297.75, indicating a potential upside of 58.25%. Given Craneware's stronger consensus rating and higher probable upside, analysts plainly believe Craneware is more favorable than Induction Healthcare Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Induction Healthcare Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Craneware	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

46.3% of Induction Healthcare Group shares are held by institutional investors. Comparatively, 36.4% of Craneware shares are held by institutional investors. 54.6% of Induction Healthcare Group shares are held by insiders. Comparatively, 10.3% of Craneware shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Craneware has a net margin of 10.63% compared to Induction Healthcare Group's net margin of -23.86%. Craneware's return on equity of 6.65% beat Induction Healthcare Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Induction Healthcare Group	-23.86%	-14.58%	-7.32%
Craneware	10.63%	6.65%	2.28%

In the previous week, Craneware had 1 more articles in the media than Induction Healthcare Group. MarketBeat recorded 1 mentions for Craneware and 0 mentions for Induction Healthcare Group. Induction Healthcare Group's average media sentiment score of 0.00 equaled Craneware'saverage media sentiment score.

Company	Overall Sentiment
Induction Healthcare Group	Neutral
Craneware	Neutral

Induction Healthcare Group has a beta of -0.41, suggesting that its share price is 141% less volatile than the broader market. Comparatively, Craneware has a beta of 0.28, suggesting that its share price is 72% less volatile than the broader market.

Summary

Craneware beats Induction Healthcare Group on 13 of the 15 factors compared between the two stocks.

Get Craneware News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CRW vs. The Competition

Export

Metric	Craneware	Health Information Services Industry	Medical Sector	LON Exchange
Market Cap	£497.12M	£347.09M	£6.74B	£2.80B
Dividend Yield	2.34%	5.60%	2.67%	6.18%
P/E Ratio	23.08	230.11	24.14	366.94
Price / Sales	2.35	127.61	511.88	86,476.21
Price / Cash	14.72	47.14	27.48	27.85
Price / Book	1.56	5.54	10.47	7.77
Net Income	£14.27M	-£22.78M	£3.56B	£5.89B
7 Day Performance	-2.55%	0.03%	0.87%	0.76%
1 Month Performance	2.98%	4.08%	1.82%	1.84%
1 Year Performance	-26.67%	-8.60%	25.66%	73.86%

Craneware Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CRW Craneware	2.6165 of 5 stars	GBX 1,452 +0.8%	GBX 2,297.75 +58.2%	-27.3%	£497.12M	£211.33M	23.08	734	Gap Up
EMIS EMIS Group	N/A	N/A	N/A	N/A	£1.23B	£176.86M	4,085.11	1,560
INS Instem	N/A	N/A	N/A	N/A	£199.62M	£61.63M	5,928.57	500
KOO Kooth	1.9469 of 5 stars	GBX 158 flat	GBX 330 +108.9%	-2.1%	£57.31M	£63.29M	22.57	478
COG Cambridge Cognition	N/A	GBX 39 +5.4%	GBX 56 +43.6%	-3.2%	£18.16M	£9.40M	N/A	80	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:CRW) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Craneware (CRW) Competitors

CRW vs. EMIS, INS, KOO, COG, and INHC

How does Craneware compare to EMIS Group?

Summary

How does Craneware compare to Instem?

Summary

How does Craneware compare to Kooth?

Summary

How does Craneware compare to Cambridge Cognition?

Summary

How does Craneware compare to Induction Healthcare Group?

Summary

Media Sentiment Over Time

CRW vs. The Competition

Craneware Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Craneware (CRW) Competitors

CRW vs. EMIS, INS, KOO, COG, and INHC

How does Craneware compare to EMIS Group?

Does the media favor CRW or EMIS?

Do analysts recommend CRW or EMIS?

Which has more risk & volatility, CRW or EMIS?

Which has better earnings and valuation, CRW or EMIS?

Do insiders & institutionals have more ownership in CRW or EMIS?

Is CRW or EMIS a better dividend stock?

Is CRW or EMIS more profitable?

Summary

How does Craneware compare to Instem?

Which has stronger earnings & valuation, CRW or INS?

Do institutionals & insiders hold more shares of CRW or INS?

Is CRW or INS more profitable?

Do analysts rate CRW or INS?

Which has more risk & volatility, CRW or INS?

Does the media refer more to CRW or INS?

Summary

How does Craneware compare to Kooth?

Which has more volatility and risk, KOO or CRW?

Do insiders & institutionals have more ownership in KOO or CRW?

Do analysts recommend KOO or CRW?

Is KOO or CRW more profitable?

Which has higher valuation & earnings, KOO or CRW?

Does the media favor KOO or CRW?

Summary

How does Craneware compare to Cambridge Cognition?

Do institutionals and insiders hold more shares of COG or CRW?

Do analysts rate COG or CRW?

Is COG or CRW more profitable?

Which has more risk and volatility, COG or CRW?

Does the media prefer COG or CRW?

Which has better valuation & earnings, COG or CRW?

Summary

How does Craneware compare to Induction Healthcare Group?

Which has stronger valuation and earnings, INHC or CRW?

Do analysts rate INHC or CRW?

Do insiders & institutionals hold more shares of INHC or CRW?

Is INHC or CRW more profitable?

Does the media prefer INHC or CRW?

Which has more volatility & risk, INHC or CRW?

Summary

Media Sentiment Over Time

CRW vs. The Competition

Craneware Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools